Skip to main content
. 2021 Sep 22;10(10):1223. doi: 10.3390/pathogens10101223

Figure 1.

Figure 1

Q fever vaccine development strategies. (a) The currently licensed phase I whole-cell vaccine (WCV), Q-Vax®, is characterized by logistical pros (green check mark) and cons (red circle); (b) experimental tools associated with advancement towards (c) an improved Q fever vaccine.